Literature DB >> 31275068

Tailored Medical Management of the Complex Postoperative Crohn's Disease Patient.

Jean-Paul Achkar1.   

Abstract

Despite advancements in medical therapy, many patients with Crohn's disease continue to require surgery for intestinal resection and/or management of perianal disease at some point in their disease course. Unfortunately, in this complex group of patients, postoperative disease recurrence rates are high. Medical prophylaxis can be used to prevent Crohn's disease recurrence or manage residual disease after surgery, but the ideal timing to start medications after surgery varies based on patient risk factors and patient preference for medication use. Currently, the largest medical treatment effects are seen with thiopurines and antitumor necrosis factor antibodies, but there are continually expanding options as new medical therapies are developed. A proposed algorithm stratified based on patient risk factors is provided.

Entities:  

Keywords:  Crohn's disease; antitumor necrosis factor antibodies; postoperative recurrence; thiopurines

Year:  2019        PMID: 31275068      PMCID: PMC6606319          DOI: 10.1055/s-0039-1683853

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  32 in total

1.  Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum.

Authors:  P Rutgeerts; K Goboes; M Peeters; M Hiele; F Penninckx; R Aerts; R Kerremans; G Vantrappen
Journal:  Lancet       Date:  1991-09-28       Impact factor: 79.321

2.  Recurrence of Crohn's disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial.

Authors:  Robin S McLeod; Bruce G Wolff; Sue Ross; Robert Parkes; Margaret McKenzie
Journal:  Dis Colon Rectum       Date:  2009-05       Impact factor: 4.585

3.  Infliximab prevents Crohn's disease recurrence after ileal resection.

Authors:  Miguel Regueiro; Wolfgang Schraut; Leonard Baidoo; Kevin E Kip; Antonia R Sepulveda; Marilyn Pesci; Janet Harrison; Scott E Plevy
Journal:  Gastroenterology       Date:  2008-10-31       Impact factor: 22.682

Review 4.  Surgery for adult Crohn's disease: what is the actual risk?

Authors:  Guillaume Bouguen; Laurent Peyrin-Biroulet
Journal:  Gut       Date:  2011-05-24       Impact factor: 23.059

5.  Smoking cessation and the course of Crohn's disease: an intervention study.

Authors:  J Cosnes; L Beaugerie; F Carbonnel; J P Gendre
Journal:  Gastroenterology       Date:  2001-04       Impact factor: 22.682

Review 6.  Pathogenesis of postoperative recurrence in Crohn's disease.

Authors:  Tasneem Ahmed; Florian Rieder; Claudio Fiocchi; Jean-Paul Achkar
Journal:  Gut       Date:  2010-11-29       Impact factor: 23.059

7.  Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms.

Authors:  G Olaison; K Smedh; R Sjödahl
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

Review 8.  Meta-analysis of the role of granulomas in the recurrence of Crohn disease.

Authors:  Constantinos Simillis; Michael Jacovides; George E Reese; Takayuki Yamamoto; Paris P Tekkis
Journal:  Dis Colon Rectum       Date:  2010-02       Impact factor: 4.585

9.  The effect of smoking after surgery for Crohn's disease: a meta-analysis of observational studies.

Authors:  George E Reese; Theodore Nanidis; Catherine Borysiewicz; Takayuki Yamamoto; Timothy Orchard; Paris P Tekkis
Journal:  Int J Colorectal Dis       Date:  2008-09-02       Impact factor: 2.571

10.  Crohn's disease patients who quit smoking have a reduced risk of reoperation for recurrence.

Authors:  William R Ryan; Robert N Allan; Takayuki Yamamoto; Michael R B Keighley
Journal:  Am J Surg       Date:  2004-02       Impact factor: 2.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.